- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CS1003 Placebo Lenvatinib
Total 54399 results
-
Sun Yat-sen UniversityNot yet recruitingPotentially Resectable Hepatocellular Carcinoma
-
Fudan UniversityRecruiting
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownCholangiocarcinoma, IntrahepaticChina
-
Fujian Medical UniversityRecruiting
-
Zhejiang Cancer HospitalRecruitingHepatocellular Carcinoma | Oxaliplatin | TACE | Lenvatinib | Tislelizumab | PharmorubicinChina
-
Henan Cancer HospitalRecruiting
-
Fudan UniversityRecruitingPancreatic Ductal AdenocarcinomaChina
-
National University Hospital, SingaporeRecruitingAdenocarcinomas | Recurrent GynecologicalSingapore
-
Tianjin Medical University Cancer Institute and...UnknownHepatocellular Carcinoma Non-resectableChina
-
CStone PharmaceuticalsTerminated
-
CStone PharmaceuticalsCompletedLocally Advanced or Metastatic Solid TumorsChina
-
MedDay Pharmaceuticals SAEurofins OptimedTerminatedHealthy Volunteers | Hepatic Impairment of Moderate Child Pugh CategoryFrance, Hungary
-
QIAGEN Gaithersburg, IncCompleted
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Sun Yat-sen UniversityRecruiting
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.Recruiting
-
Xinrui ZhuEnrolling by invitationHepatocellular Carcinoma Non-resectable | Tyrosine Kinase Inhibitor | Transarterial Chemoembolization | Immune Checkpoint BlockadeChina
-
RenJi HospitalCompletedLenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular CarcinomaHepatocellular Carcinoma | Molecular Targeted TherapyChina
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingHepatocellular Carcinoma Stage III
-
Shanghai Zhongshan HospitalWest China Hospital; Tongji Hospital; Anhui Provincial HospitalUnknownHepatocellular Carcinoma (HCC)China
-
Chen XiaopingRecruiting
-
Peking UniversityRecruitingHepatocellular Carcinoma | Portal Vein ThrombosisChina
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
Fudan UniversityRecruitingAdvanced Hepatocellular CarcinomaChina
-
Tianjin Medical University Cancer Institute and...RecruitingPotentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder CancerChina
-
Peking Union Medical College HospitalShanghai Junshi Bioscience Co., Ltd.RecruitingAdvanced Biliary Tract CancerChina
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruitingClassic Kaposi Sarcoma | Kaposi Sarcoma | Refractory Kaposi Sarcoma
-
Sun Yat-sen UniversityRecruitingHepatocellular CarcinomaChina
-
CStone PharmaceuticalsCompleted
-
QIAGEN Gaithersburg, IncCompletedTuberculosisUnited States
-
QIAGEN Gaithersburg, IncCompleted
-
Maruho Co., Ltd.Completed
-
Biotheus Inc.RecruitingAdvanced Solid TumorsChina
-
CochlearAvaniaCompleted
-
Tianjin Medical University Second HospitalRecruiting
-
BeiGeneActive, not recruiting
-
Shanghai Zhongshan HospitalEnrolling by invitationHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalEnrolling by invitationHepatocellular CarcinomaChina
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompleted
-
Jinling Hospital, ChinaRecruitingNeoplasms | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Kidney Diseases | Urologic Diseases | Carcinoma | Antineoplastic Agents | Male Urogenital Diseases | Female Urogenital Diseases | Immune Checkpoint Inhibitors | Urogenital DiseasesChina
-
M.D. Anderson Cancer CenterSTRATEGIC ALLIANCE: MerckRecruiting
-
Peking Union Medical College HospitalRecruitingBiliary Tract Neoplasms | ImmunotherapyChina
-
University College, LondonMerck Sharp & Dohme LLCRecruitingHepatocellular CarcinomaUnited Kingdom
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma Non-resectableChina
-
Cancer Hospital of Guangxi Medical UniversityActive, not recruitingTACE | Lenvatinib | Tislelizumab | Advanced Unresectable Hepatocellular CarcinomaChina
-
Wen TianfuRecruitingAdvanced Hepatocellular CarcinomaChina
-
RenJi HospitalRecruitingHepatocellular Carcinoma | Liver Cancer | Resistant CancerChina
-
Abramson Cancer Center at Penn MedicineMerck Sharp & Dohme LLCRecruitingRenal Cell CarcinomaUnited States